A Retrospective Survey among SARS-CoV-1 Infected Healthcare Workers after Three Years Post-Infection
Open Access
Abstract
Healthcare workers (HCWs) are on the frontline fighting several infectious diseases including SARS-CoV-1 and COVID-19. Coronavirus neutralizing antibodies (nAbs) were recently reported to last for a certain period. The factors affecting nAbs’ existence remain unclear. Here, we retrospectively analyzed the factors correlating with nAbs’ from SARS-CoV-1 long-term convalescence HCWs in Taiwan. One hundred and thirty SARS-CoV-1 convalescent patients were recruited between August 2006 and March 2007. Blood samples were collected to determine the anti-nucleocapsid (N) and anti-spike (S) antibodies’ existence status and neutralization ability. Neutralization ability was measured using SARS-CoV-1 pseudotyped viruses. Statistical analysis of factors associated with anti-SARS-CoV-1 antibodies’ existence status was determined using SAS software. 46.2% SARS-CoV-1 convalescent patients presented anti-N antibody after three years post-infection. Among sixty participants, ten participants co-presented anti-S antibodies. Eight participants with anti-S antibody displayed neutralization ability to SARS-CoV-1. The gender, age, and disease severity of participants did not affect the anti-N antibody existence status, whereas the anti-S antibody is significantly reduced in participants with old age (>50 years, p = 0.0434) after three years post SARS-CoV-1 infection. This study suggests that age is an important factor correlated with the duration of SARS-CoV-1 protective antibody existence status.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (108-2320-B-037-035-MY3)
This publication has 26 references indexed in Scilit:
- Human-Leukocyte Antigen Class I Cw 1502 and Class II DR 0301 Genotypes Are Associated with Resistance to Severe Acute Respiratory Syndrome (SARS) InfectionViral Immunology, 2011
- Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up StudyThe Journal of Immunology, 2011
- Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infectionArchives of Virology, 2009
- Duration of Antibody Responses after Severe Acute Respiratory SyndromeEmerging Infectious Diseases, 2007
- Disappearance of Antibodies to SARS-Associated Coronavirus after RecoveryNew England Journal of Medicine, 2007
- Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patientsVirology, 2006
- Two‐Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory SyndromeThe Journal of Infectious Diseases, 2006
- Epidemiological and Genetic Correlates of Severe Acute Respiratory Syndrome Coronavirus Infection in the Hospital with the Highest Nosocomial Infection Rate in Taiwan in 2003Journal of Clinical Microbiology, 2006
- Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronavirusesProceedings of the National Academy of Sciences, 2005
- Effects of a SARS-associated coronavirus vaccine in monkeysThe Lancet, 2003